日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma

Erdafitinib治疗FGFR改变的晚期或转移性胆管癌患者

Pant, Shubham; Park, Joon Oh; Su, Wu-Chou; Loriot, Yohann; Carranza, Omar; Corassa, Marcelo; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Prenen, Hans; Folprecht, Gunnar; Winter, Helen; Dal Molin, Graziela Z; Shen, Lin; Qian, Jiaqi; Liao, Huimin; Thomas, Shibu; Sweiti, Hussein; Triantos, Spyros; Feng, Yin-Hsun

STAT1 drives the immune landscape of murine Toll-like receptor 9-induced liver inflammation

STAT1 驱动小鼠 Toll 样受体 9 诱导的肝脏炎症的免疫微环境

De Visscher, Amber; Beliën, Jarne; Bernaerts, Eline; Vandeput, Marte; Malengier-Devlies, Bert; Prenen, Fran; Meers, Hanne; Sokol, Liliana; Mitera, Tania; Berghmans, Nele; Anak, Seray; Govaere, Olivier; Van den Steen, Philippe; Lamote, Jochen; Vandamme, Niels; Bujko, Anna; Scott, Charlotte L; Wouters, Carine H; Matthys, Patrick

DRP1 depletion protects NK cells from hypoxia-induced dysfunction

DRP1 缺失可保护 NK 细胞免受缺氧诱导的功能障碍影响。

Verhezen, Tias; Van Den Eynde, Astrid; Verstraelen, Peter; Gehrcken, Laura; Palmiotto, Gabriele; Lau, Ho Wa; De Vos, Winnok H; Van Der Heijden, Sanne; Brants, Louize; Melis, Jöran; Van Audenaerde, Jonas; Rodrigues Fortes, Felicia; Le Compte, Maxim; Roeyen, Geert; Prenen, Hans; Campillo-Davo, Diana; Lion, Eva; Argüello, Rafael J; Van Laere, Steven; Lardon, Filip; Deben, Christophe; Wouters, An; Smits, Evelien; De Waele, Jorrit

Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns

人胰腺导管腺癌中TIGIT轴组分的蛋白质水平分析揭示了免疫抑制表达模式

Quatannens, D; Verhoeven, Y; van der Heijden, S; Peeters, D; Claes, J; Hermans, C; Lambrechts, H; Zwaenepoel, K; van Dam, P; Peeters, M; Prenen, H; Koljenovic, S; De Waele, J; Faes, C; Lardon, F; Roeyen, G; Smits, E; Van Audenaerde, J

Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors

Beamion PANTUMOR-1:zongertinib治疗HER2过表达/扩增或HER2突变实体瘤的II期试验的理论依据和设计

Schram, Alison M; Park, John J; Italiano, Antoine; Kitano, Shigehisa; Guo, Ye; Li, Jin; Bedard, Philippe L; van Marcke, Cedric; Ko, Ryo; Lunger, Lukas; Klotz, Daniel M; Hussain, Jo; Maier, Daniela; Erzen, Damijan; Planchard, David; Prenen, Hans; Clay, Timothy D; Park, Joon O; Kim, Hyung-Don; Hernando-Calvo, Alberto; Maruki, Yuta; Ponz-Sarvise, Mariano; Dumbrava, Ecaterina

Single-Agent Divarasib in Patients With KRAS G12C-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study

Divarasib 单药治疗 KRAS G12C 阳性非小细胞肺癌患者:一项 I 期研究的长期随访

Sacher, Adrian G; Miller, Wilson H Jr; Patel, Manish R; Paz-Ares, Luis; Santoro, Armando; Ahn, Myung-Ju; Dziadziuszko, Rafal; Freres, Pierre; Luo, Jia; Bowyer, Samantha; Desai, Jayesh; Markman, Ben; De Miguel, Maria; Deva, Sanjeev; Falcon, Alejandro; Alonso, Guzman; Guedes, João Daniel; Kim, Se Hyun; Krebs, Matthew G; Laurie, Scott A; Massarelli, Erminia; Medina, Laura; Prenen, Hans; Amatu, Alessio; Van Dongen, Marloes; Choi, Yoonha; Hou, Xuefeng; Qi, Ting; Lin, Mark T; Koli, Kalpesh; Mayo, Mariah C; Yau, Kenneth K; Royer-Joo, Stephanie; Chang, Julie; Jun, Tomi; Dharia, Neekesh V; Schutzman, Jennifer L; Lorusso, Patricia

CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1

CD40激动剂mitazalimab联合mFOLFIRINOX方案治疗未经治疗的转移性胰腺癌:OPTIMIZE-1研究中与疗效相关的生物标志物

Jean-Luc Van Laethem ,Karen Geboes ,Ivan Borbath ,Teresa Macarulla Mercade ,Aurélien Lambert ,Philippe Cassier ,Hans Prenen ,Emmanuel Mitry ,Jean-Frédéric Blanc ,Lorenzo Pilla ,Jaime Feliu ,Mercedes Rodriguez Garrote ,Roberto Antonio Pazo-Cid ,Inmaculada Gallego ,Karin Enell Smith ,Karin Nordbladh ,David Gomez Jimenez ,Peter Ellmark ,Yago Pico de Coaña ,Sumeet Vijay Ambarkhane ,Gregory L Beatty ,Eileen M O'Reilly

JAK/STAT inhibition protects glucocorticoid receptor knockout mice from lethal malaria-induced hypoglycemia and hyperinflammation

JAK/STAT抑制剂可保护糖皮质激素受体敲除小鼠免受疟疾引起的致命性低血糖和过度炎症的影响

Fran Prenen # ,Leen Vandermosten # ,Sofie Knoops ,Emilie Pollenus ,Hendrik Possemiers ,Pauline Dagneau de Richecour ,Giorgio Caratti ,Christopher Cawthorne ,Sabine Vettorazzi ,Yevva Cranshoff ,Dominique Schols ,Sandra Claes ,Christophe M Deroose ,Uwe Himmelreich ,Jan Tuckermann ,Philippe E Van den Steen

Transarterial chemoembolisation with irinotecan (irinotecan-TACE) as salvage or post-inductive therapy for colorectal cancer liver metastases: effectiveness results from the CIREL study

伊立替康经动脉化疗栓塞术(伊立替康-TACE)作为结直肠癌肝转移的挽救性或诱导治疗后治疗:CIREL 研究的疗效结果

Arnold, D; Pereira, P L; Iezzi, R; Gjoreski, A; Spiliopoulos, S; Helmberger, T; Gomez, F M; de Baère, T; Pellerin, O; Maleux, G; Prenen, H; Sangro, B; Zeka, B; Kaufmann, N C; Taieb, J

A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer

面向晚期癌症患者的全国性综合基因组分析和分子肿瘤委员会平台

Volders, Pieter-Jan; Aftimos, Philippe; Dedeurwaerdere, Franceska; Martens, Geert; Canon, Jean-Luc; Beniuga, Gabriela; Froyen, Guy; Van Huysse, Jacques; De Pauw, Rebecca; Prenen, Hans; Lambin, Suzan; Decoster, Lore; Vaeyens, Freya; Rottey, Sylvie; Van Dam, Pieter-Jan; Decoster, Lynn; Rutten, Annemie; Schreuer, Max; Loontiens, Siebe; Van der Meulen, Joni; Mebis, Jeroen; Cuppens, Kristof; Tejpar, Sabine; Vanden Bempt, Isabelle; De Grève, Jacques; Schröder, David; van Marcke, Cédric; Van Den Bulcke, Marc; de Azambuja, Evandro; Punie, Kevin; Maes, Brigitte